1. Home
  2. PTY vs TMDX Comparison

PTY vs TMDX Comparison

Compare PTY & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pimco Corporate & Income Opportunity Fund

PTY

Pimco Corporate & Income Opportunity Fund

HOLD

Current Price

$10.90

Market Cap

2.6B

Sector

Finance

ML Signal

HOLD

Logo TransMedics Group Inc.

TMDX

TransMedics Group Inc.

HOLD

Current Price

$85.50

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PTY
TMDX
Founded
N/A
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.6B
IPO Year
2002
2019

Fundamental Metrics

Financial Performance
Metric
PTY
TMDX
Price
$10.90
$85.50
Analyst Decision
Buy
Analyst Count
0
9
Target Price
N/A
★ $148.22
AVG Volume (30 Days)
★ 1.7M
643.5K
Earning Date
01-01-0001
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 382.18
EPS
N/A
★ 0.61
Revenue
N/A
★ $605,494,000.00
Revenue This Year
N/A
$24.25
Revenue Next Year
N/A
$18.75
P/E Ratio
★ N/A
$137.54
Revenue Growth
N/A
★ 37.13
52 Week Low
$10.65
$60.11
52 Week High
$14.69
$156.00

Technical Indicators

Market Signals
Indicator
PTY
TMDX
Relative Strength Index (RSI) 30.36 48.11
Support Level N/A $80.29
Resistance Level $11.92 $90.67
Average True Range (ATR) 0.17 4.04
MACD -0.07 -0.41
Stochastic Oscillator 23.77 52.88

Price Performance

Historical Comparison
PTY
TMDX

About PTY Pimco Corporate & Income Opportunity Fund

PIMCO Corporate & Income Opportunity Fds operates as a closed-end management investment company. It seeks to maximize total return through a combination of current income and capital appreciation. The fund invests a majority of the total assets in a combination of corporate debt obligations of varying maturities, other corporate income-producing securities, and income-producing securities of non-corporate issuers, such as U.S. Government securities, municipal securities, and mortgage-backed and other asset-backed securities issued on a public or private basis.

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Share on Social Networks: